| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00094 | 1 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.00088 | 1 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.00079 | 1 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | -0.00081 | 1 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.00091 | 1 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.00053 | 1 |